Interview in Penserpodden
11 February, 2021
CEO Andreas Bhagwani interviewed in Erik Penser Bank’s podcast Penserpodden. Available on this link and on Spotify.
Latest news
Categories
News archive
Job Opening – Process Chemist
10 February, 2021
We are currently looking for a Process Chemist who likes to solve problems and develop optimised ways of working. You will work closely with our manufacturing unit, but it is R&D that is hosting this position. Formulation and chemical modification are key words! Read more about the job and how to apply here: Job advertisement Process Chemist at Nanologica Last application date: Feb 25, 2021.
Nanologica Signs Collaboration Agreement with Zentiva for the use of NLAB Drug Delivery Platforms
27 January, 2021
A collaboration agreement for the use of the NLAB drug delivery platforms has been signed with Zentiva, a pharmaceutical company operating in Europe and beyond. The aim of this collaboration agreement is to simplify the contract process for future product-specific agreements. The agreement gives Zentiva the right to use the NLAB drug delivery platforms for multiple drug development projects. Project specific agreements will be signed separately under this collaboration agreement. ” We first met Zentiva
Test Material from Large Scale Production Approved
25 January, 2021
The first batch of test material from the large-scale production of Nanologica AB’s silica has been approved. The quality of the material produced at the CMO Sterling Pharma Solutions in the UK is identical to the material produced at Nanologica’s plant in Södertälje. In December 2020, the first batch of test material from the upscaling to large-scale production of Nanologica’s silica was delivered. Rigorous quality testing of the silica now confirms identical quality to the
Nanologica Engages Scientific Advisors within Inhalation
19 January, 2021
Nanologica AB has engaged two senior scientific advisors within the field of respiratory drug delivery, for the purpose of advancing the NLAB Spiro™ inhalation platform further. Dr. John Pritchard has more than 40 years of experience from the inhalation industry working in various positions, leading and managing global portfolios of technology projects from discovery to market, at for example GlaxoSmithKline, 3M Health Care Ltd and as Head of Respiratory Project Management at AstraZeneca. His vast